Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis

[1]  G. Ho.  Faculty Opinions recommendation of Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. , 2015 .

[2]  A. Griffiths,et al.  Utility of Neutrophil Fc&ggr; Receptor I (CD64) Index as a Biomarker for Mucosal Inflammation in Pediatric Crohn's Disease , 2014, Inflammatory bowel diseases.

[3]  Markus F. Neurath,et al.  Cytokines in inflammatory bowel disease , 2014, Nature Reviews Immunology.

[4]  C. Berek,et al.  Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. , 2014, Immunity.

[5]  Y. Belkaid,et al.  Microbiota-Dependent Crosstalk Between Macrophages and ILC3 Promotes Intestinal Homeostasis , 2014, Science.

[6]  R. Locksley,et al.  Type 2 innate lymphoid cells control eosinophil homeostasis , 2013, Nature.

[7]  H. Simon,et al.  Living and dying for inflammation: neutrophils, eosinophils, basophils. , 2013, Trends in immunology.

[8]  James J. Lee,et al.  The consequences of not having eosinophils , 2013, Allergy.

[9]  M. Kagnoff,et al.  GM-CSF Produced by Nonhematopoietic Cells Is Required for Early Epithelial Cell Proliferation and Repair of Injured Colonic Mucosa , 2013, The Journal of Immunology.

[10]  M. Rothenberg,et al.  Targeting eosinophils in allergy, inflammation and beyond , 2013, Nature Reviews Drug Discovery.

[11]  L. Biancone,et al.  Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn’s Disease , 2013, PloS one.

[12]  F. Powrie,et al.  Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23-Driven Chronic Intestinal Inflammation , 2012, Immunity.

[13]  Kelley E. Capocelli,et al.  Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis , 2012, Gut.

[14]  K. Dyer,et al.  Eosinophils: changing perspectives in health and disease , 2012, Nature Reviews Immunology.

[15]  J. Macdonald,et al.  Sargramostim (GM‐CSF) for Induction of Remission in Crohn's Disease: A Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Systematic Review of Randomized Trials , 2012, Inflammatory bowel diseases.

[16]  Yinhe Feng,et al.  Expression and preliminary functional analysis of Siglec-F on mouse macrophages , 2012, Journal of Zhejiang University SCIENCE B.

[17]  J. Ledford,et al.  Surfactant Protein-A Suppresses Eosinophil-Mediated Killing of Mycoplasma pneumoniae in Allergic Lungs , 2012, PloS one.

[18]  James J. Lee,et al.  The development of a sensitive and specific ELISA for mouse eosinophil peroxidase: assessment of eosinophil degranulation ex vivo and in models of human disease. , 2012, Journal of immunological methods.

[19]  C. Bain,et al.  Mucosal Macrophages in Intestinal Homeostasis and Inflammation , 2011, Journal of Innate Immunity.

[20]  Jin-tian Tang,et al.  Regulator of calcineurin 1 (Rcan1) is required for the development of pulmonary eosinophilia in allergic inflammation in mice. , 2011, The American journal of pathology.

[21]  K. Aozasa,et al.  SIRPα/CD172a Regulates Eosinophil Homeostasis , 2011, The Journal of Immunology.

[22]  H. Kita.  Eosinophils: multifaceted biological properties and roles in health and disease , 2011, Immunological reviews.

[23]  K. Dyer,et al.  Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry. , 2011, Journal of immunological methods.

[24]  Fiona Powrie,et al.  Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.

[25]  A. Kurosky,et al.  Priming of Eosinophils by GM-CSF Is Mediated by Protein Kinase CβII-Phosphorylated L-Plastin , 2011, The Journal of Immunology.

[26]  F. Safavi,et al.  The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF , 2011, Nature Immunology.

[27]  F. Liew,et al.  IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation , 2010, The Journal of Immunology.

[28]  James J. Lee,et al.  Murine lung eosinophil activation and chemokine production in allergic airway inflammation , 2010, Cellular and Molecular Immunology.

[29]  M. Kagnoff,et al.  GM-CSF-facilitated dendritic cell recruitment and survival govern the intestinal mucosal response to a mouse enteric bacterial pathogen. , 2010, Cell host & microbe.

[30]  K. Takatsu,et al.  IL-5- and eosinophil-mediated inflammation: from discovery to therapy. , 2009, International immunology.

[31]  Xuexian O Yang,et al.  IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation , 2009, Cell Research.

[32]  G. Gleich,et al.  Eosinophil Ribonucleases and Their Cutaneous Lesion-Forming Activity1 , 2009, The Journal of Immunology.

[33]  James J. Lee,et al.  Intestinal Macrophage/Epithelial Cell-Derived CCL11/Eotaxin-1 Mediates Eosinophil Recruitment and Function in Pediatric Ulcerative Colitis1 , 2008, The Journal of Immunology.

[34]  M. Hatano,et al.  IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. , 2008, American journal of respiratory and critical care medicine.

[35]  P. Crocker,et al.  Siglec‐F antibody administration to mice selectively reduces blood and tissue eosinophils , 2008, Allergy.

[36]  D. Voehringer,et al.  Analysis of Eosinophil Turnover In Vivo Reveals Their Active Recruitment to and Prolonged Survival in the Peritoneal Cavity1 , 2007, The Journal of Immunology.

[37]  David Voehringer,et al.  Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages , 2007, Journal of leukocyte biology.

[38]  F. Powrie,et al.  Interleukin-23 drives innate and T cell–mediated intestinal inflammation , 2006, The Journal of experimental medicine.

[39]  A. Sher,et al.  IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.

[40]  C. Parkos,et al.  Neutrophil Transepithelial Migration and Epithelial Barrier Function in IBD , 2006, Annals of the New York Academy of Sciences.

[41]  Carl Nathan,et al.  Neutrophils and immunity: challenges and opportunities , 2006, Nature Reviews Immunology.

[42]  K. Akashi,et al.  Identification of eosinophil lineage–committed progenitors in the murine bone marrow , 2005, The Journal of experimental medicine.

[43]  James J. Lee,et al.  Immunopathogenesis of Experimental Ulcerative Colitis Is Mediated by Eosinophil Peroxidase1 , 2004, The Journal of Immunology.

[44]  P. Crocker,et al.  The murine inhibitory receptor mSiglec‐E is expressed broadly on cells of the innate immune system whereas mSiglec‐F is restricted to eosinophils , 2004, European journal of immunology.

[45]  T. Toyota,et al.  Increased Secretion of Granulocyte-Macrophage Colony-Stimulating Factor in Mucosal Lesions of Inflammatory Bowel Disease , 2001, Digestion.

[46]  I. Hirata,et al.  Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease , 1999, American Journal of Gastroenterology.

[47]  James J. Lee,et al.  Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. , 1999, The Journal of clinical investigation.

[48]  K. Kyokane,et al.  Increased mucosal production of granulocyte colony‐stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease , 1999, Journal of gastroenterology and hepatology.

[49]  M. Manns,et al.  Quantification of Inflammatory Mediators in Stool Samples of Patients with Inflammatory Bowel Disorders and Controls , 1997, Digestive Diseases and Sciences.

[50]  M. Jordana,et al.  Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils , 1994, The Journal of experimental medicine.

[51]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[52]  M. Tomonaga,et al.  Biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor: effect on normal bone marrow and leukemia cell lines. , 1986, Blood.